Brief: Xspray Q4 Revenue SEK 0

Xspray Pharma publ AB

12/02/2025 07:00

Feb 12 (Reuters) - Xspray Q4 adjusted EPS SEK -2.36.
* Q4 adjusted free cash flow SEK -61.601 million
* Q4 pretax profit SEK -82.002 million